MedTrace Logo

Study of Retinal and Choriocapillary Vascular Changes in Patients Undergoing Tadalafil 20mg

NCT04164355 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2021-09-24

No results posted yet for this study

Summary

This study evaluates the retinal and choriocapillary vascular features in patients under the effects of Tadalafil 20mg using optical coherence tomography angiography.

Conditions

  • Erectile Dysfunction Following Radical Prostatectomy

Interventions

DRUG

Tadalafil 20 MG

To study retinal and choriocapillary features in patients undergoing Tadalafil 20 mg orally, on alternate days, at baseline and 1, 3, 6 months after radical prostatectomy

Sponsors & Collaborators

  • Federico II University

    lead OTHER

Principal Investigators

  • Gilda Cennamo · Federico II University

Eligibility

Min Age
45 Years
Max Age
80 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-04
Primary Completion
2021-04-25
Completion
2021-04-30

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04164355 on ClinicalTrials.gov